These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1908431

  • 21. Effect of a new synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on cholesterol synthesis and low density lipoprotein uptake by primary cultures of rat hepatocytes.
    Saito Y, Shiki Y, Shirai K, Yoshida S.
    Arzneimittelforschung; 1988 Feb; 38(2):251-3. PubMed ID: 3130840
    [Abstract] [Full Text] [Related]

  • 22. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I.
    Crepaldi G, Baggio G, Arca M, Avellone G, Avogaro P, Bittolo Bon G, Bompiani GD, Capurso A, Cattin L, D'Alŏ G.
    Arch Intern Med; 1991 Jan; 151(1):146-52. PubMed ID: 1898694
    [Abstract] [Full Text] [Related]

  • 23. Effect of fluvastatin sodium on secretion of very low density lipoprotein and serum cholesterol levels. In vivo study using low density lipoprotein receptor deficient watanabe heritable hyperlipidemic rabbits.
    Shiomi M, Shiraishi M, Yata T, Ito T.
    Arzneimittelforschung; 1994 Oct; 44(10):1154-6. PubMed ID: 7818592
    [Abstract] [Full Text] [Related]

  • 24. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Chiesa G, Sirtori CR.
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [Abstract] [Full Text] [Related]

  • 25. Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia.
    Hoogerbrugge-vd Linden N, de Rooy FW, Jansen H, van Blankenstein M.
    Gut; 1990 Mar; 31(3):348-50. PubMed ID: 2108908
    [Abstract] [Full Text] [Related]

  • 26. Effects of pravastatin (CS-514) on biliary lipid metabolism in patients with hyperlipidemia.
    Horiuchi I, Ohya T, Tazuma S, Mizuno T, Takizawa I, Kajiyama G.
    Metabolism; 1991 Mar; 40(3):226-30. PubMed ID: 1900342
    [Abstract] [Full Text] [Related]

  • 27. Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat.
    Redgrave TG, Small DM.
    J Clin Invest; 1979 Jul; 64(1):162-71. PubMed ID: 221542
    [Abstract] [Full Text] [Related]

  • 28. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T, Yoshino G, Kasama T, Iwatani I, Iwai M, Morita S, Baba S.
    Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
    [No Abstract] [Full Text] [Related]

  • 29. Comparative studies on hypocholesterolemic effect of different fractions of Hyphaene thebaica (Doum) in experimental animals.
    Hetta MH, Yassin NZ.
    Pharmazie; 2006 Mar; 61(3):230-2. PubMed ID: 16599265
    [Abstract] [Full Text] [Related]

  • 30. Effects of vanadate on plasma lipoprotein profiles in experimental diabetic rats.
    Sekar N, Govindasamy S.
    Biochem Int; 1991 Mar; 23(5):935-40. PubMed ID: 1883401
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Very low density lipoprotein "remnant" particles: uptake by aortic smooth muscle cells in culture.
    Bierman EL, Eisenberg S, Stein O, Stein Y.
    Biochim Biophys Acta; 1973 Nov 02; 329(1):163-9. PubMed ID: 4361565
    [No Abstract] [Full Text] [Related]

  • 36. Mechanism of the plasma cholesterol lowering effect of tazasubrate in rats: accelerated plasma cholesterol transport with increased liver lipoprotein receptor activity.
    Diekmann HW, Sailer H, Garbe A, Nowak H, Lovati MR, Allievi L, Galbussera M, Sirtori CR.
    Pharmacol Res Commun; 1986 Mar 02; 18(3):203-16. PubMed ID: 3014569
    [Abstract] [Full Text] [Related]

  • 37. Effects of BM 15.766 on serum lipids in rats.
    Pill J, Schmidt FH, Stegmeier K, Witte EC.
    Horm Metab Res; 1985 Oct 02; 17(10):543-4. PubMed ID: 3840766
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.